| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Jun 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 27.68B | 59.98B | 59.46B | 63.04B | 107.80B |
| Gross Profit | -28.90B | -5.87B | 5.85B | 5.28B | 3.29B |
| EBITDA | 14.96B | -31.03B | -14.73B | -9.70B | -14.61B |
| Net Income | 14.10B | -35.91B | -21.03B | -21.49B | -27.09B |
Balance Sheet | |||||
| Total Assets | 357.37B | 436.43B | 543.25B | 616.21B | 628.10B |
| Cash, Cash Equivalents and Short-Term Investments | 12.19B | 11.35B | 15.19B | 22.07B | 47.83B |
| Total Debt | 182.38B | 252.11B | 264.06B | 274.14B | 231.85B |
| Total Liabilities | 344.72B | 433.08B | 492.00B | 536.71B | 514.10B |
| Stockholders Equity | -166.97M | -21.65B | 14.72B | 36.53B | 57.82B |
Cash Flow | |||||
| Free Cash Flow | 1.46B | -1.04B | -5.96B | -5.14B | -11.07B |
| Operating Cash Flow | 2.45B | -243.97M | -5.47B | -4.33B | -9.59B |
| Investing Cash Flow | -1.55B | -368.54M | 1.05B | 5.68B | -35.83B |
| Financing Cash Flow | -3.82B | -3.24B | -2.44B | -27.32B | 31.93B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$248.58B | 3.64 | 8.80% | 5.18% | 1.05% | -0.55% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
58 Neutral | HK$172.05B | 10.85 | 3.54% | 4.54% | -9.39% | -19.08% | |
58 Neutral | HK$58.07B | 51.26 | 0.65% | 3.96% | -23.93% | -90.51% | |
46 Neutral | HK$11.51B | 0.12 | -3.01% | ― | -38.67% | ― | |
44 Neutral | HK$1.27B | 0.07 | ― | ― | -52.61% | ― | |
41 Neutral | HK$46.49B | -1.28 | -59.37% | ― | -28.73% | -60.86% |